Pharmaceuticals, Biotechnology and Life Sciences
According to preliminary consolidated results of Latvian JSC Olainfarm for December 2016, sales of the Groups have reached €10.28 million, which represents an increase by 39% compared to December 2015.
U.S. Food and Drug Administration (FDA) has approved Allergan’s Rhofade skin desease cream, a topical treatment of persistent facial erythema (redness)…
Anavex has ensured most of the cash for a U.S. multicentre Phase 2 clinical trial of Rett syndrome treatment Anavex2-73.
NeuroVive Pharmaceutical’s abstract with novel preclinical cancer data related to the company’s sanglifehrin-based compounds has been accepted for presentation at…
Summit Therapeutics has named its research and development adviser Dr David Roblin as new Chief Operating Officer (COO) and President of Research Development.
PledPharma’s Nomination Committee has submitted a proposal for a new composition of the Board of Directors for consideration at an…
GlaxoSmithKline has appointed Luke Miels President, Global Pharmaceuticals, GSK. He will be responsible for a portfolio of medicines and vaccines with annual sales of more than £15 billion and operations in over 100 markets.
French drugmaker Adocia, encouraged by the outcome of its project BC Lispro, has set its goal on partnering up with companies that have “more mature projects”, such is Eli Lilly with whom Adocia worked on BC Lispro.
Horizon Pharmaceuticals has warned by the Food and Drug Administration (FDA) to better respond on resolving certain issues it had in its drug manufacturing facilities, that the FDA pointed out after an inspection in 2015.
Eli Lilly has bought a biotech company focusing on pain management, CoLucid Pharmaceuticals for approximately $960 million, ($46.50 per share)…